IP Library Granted Patent US 7,790,380
Granted Patent B2
US 7,790,380 · App. 11/437,246 · Granted Sep 7, 2010

Kits for multiplexed nucleic acid analysis by capture of single-stranded DNA produced from double-stranded target fragments

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,790,380
App. No.
11/437,246
Granted
Sep 7, 2010
Kind
B2
Abstract

A method of fragmentation of double stranded DNA is disclosed for use in nucleic acid analysis, notably in the multiplexed analysis of polymorphisms and mutations. The method produces a multiplicity of labeled sense and anti-sense fragments which are not complementary, and thus do not significantly re-anneal under conditions suitable for hybridization analysis (or capture-mediated elongation analysis) of the polymorphisms and/or mutations. The fragments display a desired or predicted length distribution. Cleavage sites can be selected such that the fragments are short, yet long enough to allow discrimination among fragments in an assay, and as a matter of statistical probability, such that the majority of fragments contain at least one labeled nucleotide to facilitate detection.

Claims (15)

1. A method for detecting particular nucleotide sequences in a double-stranded oligonucleotide sample, comprising:

amplifying segments of the sample with unlabeled primers in the presence of labeled nucleotides to generate labeled double stranded amplicons;

cleaving the double-stranded amplicons at a multiplicity of sites which are randomly distributed along each strand to produce fragments which are not fully complementary to one another;

mixing the fragments with a hybridization buffer;

placing the fragments in contact with a set of single-stranded oligonucleotides under annealing conditions, wherein single-stranded oligonucleotides in the set are complementary to the fragments or to subsequences of the fragments; and

detecting hybridization between said set of single-stranded oligonucleotides and the fragments.

2. The method according to claim 1 , wherein the labeled nucleotides are fluorescently labeled.

3. The method according to claim 1 , wherein the labeled nucleotides comprise biotin.

4. The method of claim 3 , wherein detecting comprises contacting the fragments with labeled streptavidin.

5. The method according to claim 1 , wherein cleaving comprises depurination of the amplicon by contacting the amplicon with hydrochloric acid then heat-denaturing to generate single-stranded DNA fragments.

6. The method of claim 1 , wherein fragment length is controlled by controlling the pH of the hydrochloric acid, time of exposure to the hydrochloric acid and reaction temperature.

7. The method of claim 6 , wherein fragment length is adjusted so as to generate sense and/or anti-sense fragments comparable in length to the single-stranded oligonucleotides.

8. The method of claim 1 , wherein the single-stranded oligonucleotides are DNA.

9. The method of claim 1 , wherein the double-stranded oligonucleotide sample is genomic DNA.

10. The method of claim 1 , wherein the double-stranded oligonucleotide sample includes genetic loci of interest.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0033 →
RELEASE OF SECURITY INTEREST Recorded Mar 15, 2023
From: ALTER DOMUS (US) LLC, AS COLLATERAL AGENT
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS, INC.
Reel/Frame 063090/0111 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: HPS INVESTMENT PARTNERS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0135 →
SECURITY INTEREST Recorded Jul 2, 2020
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; SIRONA GENOMICS, INC.; IMMUCOR GTI DIAGNOSTICS INC.
To: ALTER DOMUS (US) LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 053119/0152 →
RELEASE OF PATENT SECURITY INTERESTS Recorded Jul 2, 2020
From: CITIBANK, N.A.
To: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.; IMMUCOR GTI DIAGNOSTICS, INC.; SIRONA GENONICS, INC.
Reel/Frame 053121/0935 →
PATENT SECURITY AGREEMENT Recorded Aug 19, 2011
From: IMMUCOR, INC.; BIOARRAY SOLUTIONS LTD.
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 026778/0640 →